• AZAZ
  • RURU
AEM
+994 12 596 05 20
Write us
No Result
View All Result
  • About Us
  • Import
    • Documents
    • Letter samples
  • Control
    • Control on Medicines
    • Legislation
  • Registration
    • Department of Registration
    • Legislation
  • Laboratory
    • About the Quality Control Laboratory
  • Pharmacovigilance
    • General information
    • Legislation
    • Information for healthcare professionals
    • Information for Patients
    • Pharmacovigilance dictionary
    • Reporting forms
    • Online reporting
    • For MAH
    • Medicines under additional monitoring
  • Private medical institutions
    • Legislation
  • FS
    • Expertise of FS
    • Result of the Expertise of FS
  • Medical devices
    • Application form
    • MD Documents
    • Results of examination of medical devices
    • Legislation
  • MD monitoring
    • Tracking and Tracing of Medicines Department
AEM
No Result
View All Result

General information

December 1, 2022
A A
Analytical Expertise Center Pharmacovigilance department’s main activity is systematic monitoring of adverse drug reactions and risk-benefit balance to ensure the safe use of the medicines, gathering information, registering, evaluating, archiving, establishing contacts between the parties and taking the necessary measures to minimize the damage caused by drugs. Activities for this purpose are as follows:
  • Tracing, recording, evaluating, archiving adverse drug reactions, transmitting information to the Uppsala Monitoring Center of the World Health Organization;
  • By examining the official websites of World Health Centers, minimizing the risk by monitoring the warnings on pharmaceutical safety, investigating security-related applications by registering owners, taking advantage of the risk-benefit balance assessment based on these data applying appropriate measures for medicinal products which has already registered or is going to registration procedures in our country;
  • Taking the necessary measures, by investigating Risk Management Plans (RMP) and Periodic Safety Update Reports (PSUR);
  • Preparation of a list of medicines under additional monitoring;
  • Delivery of information to healthcare professionals;
  • Establishment of pharmacovigilance control system;
  • Taking the necessary measures to promote the spontaneous data transmission by healthcare professionals for the best application of pharmacovigilance system;
  • Organization of pharmacovigilance training and courses.
ShareTweetShare
AEM

© 2022 AEM - Analitik Ekspertiza Mərkəzi .

Useful links

  • About Us
  • Contact
  • Rates

Follow us

  • AZAZ
  • RURU
No Result
View All Result
  • About Us
  • Import
    • Documents
    • Letter samples
  • Control
    • Control on Medicines
    • Legislation
  • Registration
    • Department of Registration
    • Legislation
  • Laboratory
    • About the Quality Control Laboratory
  • Pharmacovigilance
    • General information
    • Legislation
    • Information for healthcare professionals
    • Information for Patients
    • Pharmacovigilance dictionary
    • Reporting forms
    • Online reporting
    • Contacts
    • For MAH
    • Medicines under additional monitoring
  • Private medical institutions
    • Legislation
  • FS
    • Expertise of FS
    • Result of the Expertise of FS
  • Medical devices
    • Application form
    • MD Documents
    • Results of examination of medical devices
    • Legislation
  • Rates
  • Contact

© 2022 AEM - Analitik Ekspertiza Mərkəzi .

Accessibility

Content Scaling
Default
Text Magnifier
Dyslexia Friendly
Highlight Links
Font Sizing
Default
Left Aligned
Center Aligned
Right Aligned
Dark Contrast
Monochrome
High Saturation
Adjust Text Colors
Adjust Title Colors
Adjust Background Colors
Hide Images
Reading Guide
Reading Mask
Highlight Hover
Big Dark Cursor
Big Light Cursor